Abstract
We prepared recombinant human interleukin-2 (rhIL-2) and studied its pretreated influence on liver regeneration and the blood profile in partially (67%) hepatectomized (PH) male Sprague-Dawley rats. Rats were injected in the tail vein with rhIL-2 three times per day for 3 consecutive days and 67% underwent a partial hepatectomy (PH). Five days after the PH, liver tissue and blood samples were analyzed for liver regeneration and hematological changes. The weight of the liver in the rhIL-2 pretreated groups increased in a dose-dependent manner; with the highest treatment (24 × 104 IU/kg), the maximum liver weight of 88.6% was exhibited. The control group showed a gradual increase to 76.3% of the original liver weight. A histological analysis of the liver showed an increase in proliferating cell nuclear antigen (PCNA)-positive cells in rhIL-2 pretreated rat livers. The rate of hepatocyte proliferation also increased significantly in primary cultured rat liver cells following rhIL-2 treatment. These results suggest that pretreatment with rhIL-2 may play adjuvant roles in liver regeneration after PH.
Similar content being viewed by others
References
Kmie, Z. (2001) Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell Biol. 161: 1–151.
Fausto, N. (2000) Liver regeneration. J. Hepatol. 32: 19–31.
Zimmermann, A. (2002) Liver regeneration: The emergence of new pathways. Med. Sci. Monit. 8: 53–63.
Mitchell, C. and H. Willenbring (2008) A reproducible and welltolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 3: 1167–1170.
Michalopoulos, G. K. (2007) Liver regeneration. Cell Physiol. 213: 286–300.
Rosenberg, S. A., E. A. Grimm, M. McGrogan, M. Doyle, E. Kawasaki, K. Koths, and D. F. Mark (1984) Biological activity of recombinant human interleukin-2 produced in Escherichia coli. Sci. 223: 1412–1414.
Sarkandy, S. Y., R. Khalilzadeh, S. A. Shojaosadati, M. Sadeghizadeh, A. M. Farnoud, V. Babaeipour, and A. Maghsoudi (2010) A novel amino acid supplementation strategy based on a stoichiometric model to enhance human IL-2 (interleukin-2) expression in high-cell-density Escherichia coli cultures. Biotechnol. Appl. Biochem. 57: 151–156.
Esfandiar, S., S. Hashemi-Najafabadi, S. A. Shojaosadati, S. A. Sarrafzadeh, and Z. Pourpak (2010) Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2. Biotechnol. Appl. Biochem. 55: 209–214.
Cameron, R. B., J. K. McIntosh, and S. A. Rosenberg (1988) Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alphainterferon in the treatment of established murine hepatic metastases. Cancer Res. 48: 5810–5817.
Greenway, A., A. Azad, and D. McPhee (1995) Human immunodeficiency virus type 1 Nef protein inhibits activation pathways in peripheral blood mononuclear cells and T-cell lines. J. Virol. 69: 1842–1850.
Gillies, S. D., Y. Lan, T. Hettmann, B. Brunkhorst, Y. Sun, S. O. Mueller, and K. M. Lo (2011) A low-toxicity IL-2-based immunocytokine retains antitumor activity despite its high degree of IL-2 receptor selectivity. Clin. Cancer Res. 17: 3673–3685.
Dooms, H. and A. K. Abbas (2010) Revisiting the role of IL-2 in autoimmunity. Eur. J. Immunol. 40: 1538–1540.
O’Gorman, W. E., H. Dooms, S. H. Thorne, W. F. Kuswanto, E. F. Simonds, P. O. Krutzik, G. P. Nolan, and A. K. Abbas (2009) The initial phase of an immune response functions to activate regulatory T cells. J. Immunol. 183: 332–339.
Li, W., S. Kubo, A. Okuda, H. Yamamoto, H. Ueda, T. Tanaka, H. Nakamura, H. Yamanishi, N. Terada, and H. Okamura (2010) Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2. J. Immunother. 33: 287–296.
Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3: 521–530.
Tinel, M., J. Elkahwaji, M. A. Robin, N. Fardel, V. Descatoire, D. Haouzi, A. Berson, and D. Pessayre (1999) Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes. J. Pharmacol. Exp. Ther. 289: 649–655.
Wadamori, K., M. Oka, N. Tokuda, Y. Fujikura, S. Hazama, T. Fukumoto, and T. Suzuki (1996) Influence of continuous interleukin-2 administration via the portal vein on liver regeneration following partial hepatectomy in rats. Hepatol. 23: 1578–1583.
Taniguchi, T., H. Matsui, T. Fujita, C. Takaoka, N. Kashima, R. Yoshimoto, and J. Hamuro (1983) Structure and expression of a cloned cDNA for human interleukin-2. Nature 302: 305–310.
Robb, R. J., R. M. Kutny, M. Panico, H. R. Morris, and V. Chowdhry (1984) Amino acid sequence and post-translational modification of human interleukin 2. Proc. Natl. Acad. Sci. USA 81: 6486–6490.
Vance, D. E. and D. S. Feingold (1971) Additive Edman degradation to sequence small peptides. Nature 229: 121–123.
Liu, X. L., L. J. Li, and Z. Chen (2001) Isolation and primary culture of rat hepatocytes. Hepatobiliary Pancreat. Dis. Int. 1: 77–79.
Theocharis, S. E., A. S. Skopelitou, A. P. Margeli, K. J. Pavlaki, and C. Kittas (1994) Proliferating cell nuclear antigen (PCNA) expression in regenerating rat liver after partial hepatectomy. Dig. Dis. Sci. 39: 245–252.
Sakiyama, J., S. Mori, M. Ichimura, H. Tohge, M. Okamoto, and H. Endo (1996) Comparative studies on the time course of proliferating cell nuclear antigen and bromodeoxyuridine staining pattern in regenerating rat liver cells. Rinsho. Byori. 44: 61–66.
Wang, A., S. D. Lu, and D. F. Mark (1984) Site-specific mutagenesis of the human interleukin-2 gene: Structure-function analysis of the cysteine residues. Science 224: 1431–1433.
Fabrikant, J. I. (1968) The kinetics of cellular proliferation in regenerating liver. J. Cell Biol. 36: 551–565.
Zou, Y., Q. Bao, S. Kumar, M. Hu, G. Y. Wang, and G. Dai (2012) Four waves of hepatocyte proliferation linked with three waves of hepatic fat accumulation during partial hepatectomy-induced liver regeneration. PLoS. One. 7: e30675.
Ochenashko, O. V., A. I. Bozhkov, and A. I. Petrenko (2002) Effect of human fetal liver cells on the rate of DNA and nRNA synthesis in regenerating rat liver. Ukr. Biokhim. Zh. 74: 25–30.
Marubashi, S., M. Sakon, H. Nagano, K. Gotoh, K. Hashimoto, M. Kubota, S. Kobayashi, S. Yamamoto, A. Miyamoto, K. Dono, S. Nakamori, K. Umeshita, and M. Monden (2004) Effect of portal hemodynamics on liver regeneration studied in a novel portohepatic shunt rat model. Surgery 136: 1028–1037.
Gebhardt, R., A. Baldysiak-Figiel, V. Krügel, E. Ueberham, and F. Gaunitz (2007) Hepatocellular expression of glutamine synthetase: An indicator of morphogen actions as master regulators of zonation in adult liver. Prog. Histochem. Cytochem. 41: 201–266.
Lumeij, J. T., J. J. De Bruijne, A. Slob, J. Wolfswinkel, and J. Rothuizen (1988) Enzyme activities in tissues and elimination half-lives of homologous muscle and liver enzymes in the racing pigeon (Columba Livia domestica). J. Avian Pathol. 17: 851–864.
Kos-Lis, K. (1988) Studies of alanine and aspartate transaminases, lactate dehydrogenase and phosphocreatine kinase levels in the cerebrospinal fluid and serum in multiple sclerosis. Neurol. Neurochir. Pol. 22: 184–187.
Sbriccoli, P., F. Felici, A. Rosponi, A. Aliotta, V. Castellano, C. Mazzà, M. Bernardi, and M. Marchetti (2001) Exercise induced muscle damage and recovery assessed by means of linear and non-linear sEMG analysis and ultrasonography. J. Electromyogr. Kinesiol. 11: 73–83.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jeon, M., Kwon, H.J., Kim, Y.H. et al. Pretreatment with recombinant human interleukin 2 (rhIL-2) Up-regulates PCNA-positive cells after partial hepatectomy in rat liver. Biotechnol Bioproc E 19, 43–51 (2014). https://doi.org/10.1007/s12257-013-0667-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-013-0667-8